RAPT THERAPEUTICS INC's ticker is RAPT and the CUSIP is 75382E109. A total of 84 filers reported holding RAPT THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.12 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $31,921,336 | -25.4% | 1,920,658 | -16.1% | 1.06% | -14.0% |
| Q2 2023 | $42,794,819 | +1.8% | 2,288,493 | -0.1% | 1.24% | -0.2% |
| Q1 2023 | $42,051,007 | +18.1% | 2,291,608 | +27.4% | 1.24% | +24.2% |
| Q4 2022 | $35,619,309 | -13.6% | 1,798,955 | +5.0% | 1.00% | -16.4% |
| Q3 2022 | $41,218,000 | +18.0% | 1,713,134 | -10.5% | 1.20% | +9.3% |
| Q2 2022 | $34,927,000 | -43.3% | 1,913,791 | -31.6% | 1.09% | -11.3% |
| Q1 2022 | $61,571,000 | -71.4% | 2,799,962 | -52.2% | 1.23% | -25.7% |
| Q4 2021 | $215,058,000 | +138.2% | 5,855,130 | +101.4% | 1.66% | +26.5% |
| Q3 2021 | $90,280,000 | -42.7% | 2,907,565 | -42.3% | 1.31% | +28.2% |
| Q2 2021 | $157,568,000 | +186.5% | 5,041,320 | +103.5% | 1.02% | +47.0% |
| Q1 2021 | $55,000,000 | +76.5% | 2,477,481 | +57.1% | 0.70% | +108.4% |
| Q4 2020 | $31,155,000 | – | 1,577,481 | – | 0.33% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ponoi Management, LLC | 1,599,417 | $31,588,000 | 18.07% |
| KPCB XV Associates, LLC | 1,947,063 | $38,454,000 | 16.52% |
| Column Group LLC | 3,885,679 | $76,742,000 | 6.96% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 1,122,237 | $22,164,000 | 3.20% |
| Euclidean Capital LLC | 735,801 | $14,532,000 | 3.08% |
| Ponoi II Management, LLC | 145,401 | $2,872,000 | 2.09% |
| Trustees of Columbia University in the City of New York | 73,383 | $1,449,000 | 1.94% |
| ACUTA CAPITAL PARTNERS, LLC | 209,600 | $4,140,000 | 1.13% |
| AJU IB Investment Co., Ltd. | 108,503 | $2,143,000 | 0.81% |
| Alphabet Inc. | 831,254 | $16,417,000 | 0.79% |